View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, Nov. 12 (HealthDay News) -- Individuals treated with isotretinoin for severe acne are at an increased risk of attempted suicide up to six months after the end of treatment, though there is already an increased risk in acne patients before treatment, so an additional risk due to treatment cannot be established, according to a study published online Nov. 11 in BMJ.
In a retrospective cohort study, Anders Sundström, of the Karolinska University Hospital in Stockholm, Sweden, and colleagues evaluated 5,756 patients aged 15 to 49 years prescribed isotretinoin for severe acne. The patients were observed before, during, and after treatment.
The researchers found that the standardized incidence ratio for attempted suicide was 1.57 for all attempts and 1.36 for first attempts during the year prior to treatment. During and up to six months after treatment, the standardized incidence ratio was 1.78 for all attempts and 1.93 for first attempts. Three years after treatment was completed, the observed number of suicide attempts was in line with the expected number, and remained so during 15 years of follow-up. The investigators also found that 38 percent of patients who made their first suicide attempt prior to treatment and 71 percent who made their first suicide attempt within six months after treatment stopped made a new attempt or committed suicide during follow-up.
"An increased risk of attempted suicide was apparent up to six months after the end of treatment with isotretinoin, which motivates a close monitoring of patients for suicidal behavior for up to a year after treatment has ended. However, the risk of attempted suicide was already rising before treatment, so an additional risk due to the isotretinoin treatment cannot be established," the authors conclude.
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top